These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23933284)

  • 1. Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection.
    Tsai HL; Yang IP; Huang CW; Ma CJ; Kuo CH; Lu CY; Juo SH; Wang JY
    Transl Res; 2013 Oct; 162(4):258-68. PubMed ID: 23933284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle.
    Yang IP; Tsai HL; Hou MF; Chen KC; Tsai PC; Huang SW; Chou WW; Wang JY; Juo SH
    Carcinogenesis; 2012 Aug; 33(8):1522-30. PubMed ID: 22581829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse.
    Yang IP; Tsai HL; Huang CW; Huang MY; Hou MF; Juo SH; Wang JY
    PLoS One; 2013; 8(6):e66842. PubMed ID: 23840538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
    J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
    Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
    Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients.
    Yang IP; Tsai HL; Miao ZF; Huang CW; Kuo CH; Wu JY; Wang WM; Juo SH; Wang JY
    J Transl Med; 2016 Apr; 14(1):108. PubMed ID: 27126129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer.
    Takahashi M; Cuatrecasas M; Balaguer F; Hur K; Toiyama Y; Castells A; Boland CR; Goel A
    PLoS One; 2012; 7(10):e46684. PubMed ID: 23056401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
    Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
    Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer.
    Hibino Y; Sakamoto N; Naito Y; Goto K; Oo HZ; Sentani K; Hinoi T; Ohdan H; Oue N; Yasui W
    Pathobiology; 2015; 82(5):233-41. PubMed ID: 26389729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection.
    Uen YH; Lu CY; Tsai HL; Yu FJ; Huang MY; Cheng TL; Lin SR; Wang JY
    Ann Surg Oncol; 2008 Aug; 15(8):2120-8. PubMed ID: 18481151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer.
    Katoh H; Yamashita K; Wang G; Sato T; Nakamura T; Watanabe M
    Ann Surg Oncol; 2011 Sep; 18(9):2432-41. PubMed ID: 21369738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma.
    Luo H; Zou J; Dong Z; Zeng Q; Wu D; Liu L
    Biochem J; 2012 Mar; 442(2):311-21. PubMed ID: 22132820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
    Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
    Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.
    Baltruskeviciene E; Schveigert D; Stankevicius V; Mickys U; Zvirblis T; Bublevic J; Suziedelis K; Aleknavicius E
    BMC Cancer; 2017 Sep; 17(1):607. PubMed ID: 28863773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
    Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Yeh YS; Chang YT; Yang IP; Lin CH; Kuo CH; Juo SH; Wang JY
    J Surg Oncol; 2013 Feb; 107(2):148-54. PubMed ID: 22926658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.